Potentiation of radiotherapy by nontoxic pretreament with combined vitamins C and K3 in mice bearing solid transplantable tumor

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 499-504

  Taper, Henryk S ^a   Keyeux, Andre ^a   Roberfroid, Marcel ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Radiotherapy potentiation; Vitamins C and K3

Indexed keywords

ASCORBIC ACID; HYDROGEN PEROXIDE; MENADIONE; OXYGEN RADICAL; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER TUMOR; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RADIATION DOSE; SOLID TUMOR; TUMOR VOLUME;

ANIMALS; ASCORBIC ACID; COMBINED MODALITY THERAPY; DRUG SYNERGISM; MALE; MICE; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RADIATION-SENSITIZING AGENTS; VITAMIN K;

EID: 0030005062     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chaplin DJ, Durand RE and Oliver PL: Acute hypoxia in tumors: Implication for modifiers of radiation effects. Int J Radiat Oncol Biol Phys 12: 1279-1282, 1986.
2. Thomlinson RH and Gray LH: The histological structure of some human lung cancers and the possible implication for radiotherapy. Br Cancer 9: 539-549, 1955.
3. Evans HH, Ricanati M and Horng M: Deficiency in DNA repair in mouse hepatoma strain L51784-S. Proc Natl Acad Sci USA 84. 7562-7566, 1987.
4. Kemp LM, Sedgwick SG and Jegga PA: X-ray sensitive mutants of chinese hamster ovary cells defective in double-strand breaks rejoining. Mutat Res 132: 189-196, 1989.
5. Wlodek D and Hittelman WN: The relationship of DNA and chromosome damage to survival of synchronized X-irradiated L5178Y cells. Repair Radiat Res 115. 566-575, 1988.
6. Giaccia A, Weinstein R, Hu J and Stamato TD: Cell cycle-dependent repair of double strain DNA breaks in a gamma-ray sensitive chinese hamster cell. Somat Cell Mol Genet 11: 485-491, 1985.
7. McKenna WG, Iliakis G, Weiss MC, Bernhard EJ and Muschel RJ: Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogene H-ras and v-myc. Radiat Res 125: 283-287, 1991.
8. Weinert TA, and Hartwell LH: The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science (Washington D.C.) 241: 317-322, 1988.
9. Stephens LC, Hunter NR, Ang KK, Milas L and Meyn RE: Development of apoptosis in irradiated murine tumors as a function of time and dose. Radical Res 135: 75-80, 1993.
10. Chapman JD: Current concepts in cancer. Hypoxic sensitizers implication for radiation therapy. N Engl J Med 26. 1429-1432, 1979.
11. Dische S: The clinical use of hyperbaric oxygen and chemical hypoxic cell sensitizers. In: Steel GG; Adams CE; Peckham MJ, eds. The Biological Basis of Radiotherapy. Amsterdam: Elsevier, 1983: 225-237.
12. Dische S: Chemical sensitizers for hypoxic cells. A decade of experience in clinical radiotherapy. Radiother Oncol 3: 97-115, 1985.
13. Withers HR: Biologic basis for altered fractionation schemes. Cancer 55: 2086-2094, 1985.
14. Grégoire V, Hunter N, Milas L, Brock WA, Plunkett W and Hittelman WN: Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine. Cancer Res 54: 468-474, 1994.
15. Leonard MP, Jeffs RD, Gearhart JP and Coffey DS: Recombinant human tumor necrosis factor enhances radiosensitivity and improves animal survival in murine neuroblastoma. J Urology 148: 743-746, 1992.
16. 3 vitamin pretreatment Int J Cancer 40: 575-579, 1987.
17. 3 with ferrous sulfate pretreatment. Oncol (Life Sci Adv) 11: 19-25, 1992a.
18. 3 pretreatment in a mouse tumor resistant to oncovin. Anticancer Res 12: 1651-1654, 1992.
19. 3) treatment on human tumor cell growth in vitro. Cancer 63: 901-906, 1989.
20. Taper HS, Wooley GW, Teller MN and Lardis MP: A new transplantable mouse liver tumor of spontaneous origin. Cancer Res 26: 143-148, 1966.
21. Cappucino JG, Brown GF, Mountain SM, Spencer S and Tarnowski GS: Chemotherapeutic studies on a new transplantable mouse liver tumor (Taper liver tumor). Cancer Res 26: 689-694, 1966.
22. Pething R, Gascoyne PRC, Mc Laughlin JA and Szent-Gyorgyi A: Ascorbate-quinone interactions. Electrochemical, free radical and cytotoxic properties. Proc Natl Acad Sci USA 80: 129-132, 1983.
23. Edgar JA: Dehydroascorbic acid and cell division. Nature (Lond). 227: 24-26, 1979.
24. Cameron E, Pauling L and Leibovitz B: Ascorbic acid and cancer: A review. Cancer Res 39: 663-681, 1979.
25. Chion SH: DNA and protein scission activities of ascorbate in the presence of copper ion and a copper-peptide complex. J Biochem 94: 1259-1267, 1983.
26. Samuni A, Aronovitch J, Godinger D, Chevion M and Czapski G: On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. Eur Biochem 137: 119-124, 1983.
27. Taper HS: Reversibility of acid and alkaline deoxyribonuclease deficiency in malignant tumor cells. J Histochem Cytochem 29: 1053-1060, 1981.
28. Benade L, Howard T and Burk D: Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-2,2,4-triazole. Oncology 23. 3343, 1969.
29. Rabilloud T, Asselineau D, Miguel C, Calvayraz R, Dermon M and Willaume M: Deficiency in catalase activity correlates with the appearance of tumor phenotype in human keratinocytes Int J Can 45: 952-956, 1990.
30. Mimnaugh EG, Dusre L, Atwell J and Meyers CE: Differential oxygen radical susceptibility of Adriamycin sensitive and resistant M.C.F.7 human breast tumor cells. Cancer Res 49: 8-15, 1989.
31. Sinha B and Mimnaugh EG: Free radicals and anticancer drug resistance: Oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors. Free Rad Bio Med 8: 567-581, 1990.
32. Bodansky O, Wroblewski D and Markardt B: Concentration of ascorbic acid in plasma and white cells of patients with cancer and noncancerous chronic diseases. Cancer Res 11: 238-242, 1951.
33. Lloyd JV, Davis PS, Emery H and Lauder H: Platelet ascorbic acid levels in normal subjects and in diseases. J Clin Pathol 25: 478-483, 1972.